SULFATION PATHWAYS: Steroid sulphatase inhibition via aryl sulphamates: clinical progress, mechanism and future prospects
Steroid sulphatase is an emerging drug target for the endocrine therapy of hormone-dependent diseases, catalysing oestrogen sulphate hydrolysis to oestrogen. Drug discovery, developing the core aryl O-sulphamate pharmacophore, has led to steroidal and non-steroidal drugs entering numerous clinical t...
Autor principal: | Potter, B |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
BioScientifica
2018
|
Ítems similars
-
SULFATION PATHWAYS: Steroid sulfatase inhibition by aryl sulfamates: clinical
progress, mechanism and future prospects
per: Potter, B
Publicat: (2018) -
Steroid Sulphatase and Its Inhibitors: Past, Present, and Future
per: Paul A. Foster
Publicat: (2021-05-01) -
New potent steroid sulphatase inhibitors based on 6-(1-phenyl-1H-1,2,3-triazol-4-yl)naphthalen-2-yl sulphamate derivatives
per: Olga Ciupak, et al.
Publicat: (2021-01-01) -
Placental steroid sulphatase deficiency: an approach to antenatal care and delivery
per: Frieda-Elsje Dreyer, et al.
Publicat: (2018-11-01) -
Recent progress in the development of steroid sulphatase inhibitors – examples of the novel and most promising compounds from the last decade
per: Mateusz Daśko, et al.
Publicat: (2020-01-01)